type here...

CATEGORIES

Policy and Practice

LATEST

1...282930...35Page 29 of 35

TRENDING

EDITORS CHOICE

Were the Billions Invested in Alzheimer’s Research Worthwhile?

Gil Bashe, Medika Life Editor -
It may seem that the COVID-19 vaccines appeared almost suddenly, like rabbits pulled from a magician’s hat, but the invention of mRNA-based vaccines that...

GLP‑1 Medications in Later Life: Why the “Miracle Shot” Needs a Senior‑Specific Safety Lens

Pat Farrell PhD -
When GLP-1 medications like semaglutide began to gain attention, many people saw them as a breakthrough. For some people, these drugs help lower blood sugar,...

Pfizer Confirms mRNA Vaccine Never Tested for Preventing COVID Transmission

Robert Turner, Founding Editor -
In a startling disclosure at the EU COVI Hearings in Brussels on the 10th of October 2022, Janine Small admitted in response to a...

The Story of The Un-Vaccinated

Jordan Forbes -
Whenever I got sick as a child, I never hesitated to take Robitussin. Why? Because I believed that the medication I was taking would...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories